Moorfields Eye Charity is delighted to support World Glaucoma Week from 10 to 16 March 2019. This important week raises awareness of glaucoma and alerts people to have regular eye (and optic nerve) checks to detect glaucoma.
What is glaucoma?
Glaucoma is the name given to a group of eye conditions in which the pressure in the eye becomes too high and the optic nerve is damaged where it leaves the eye. Glaucoma is one of the world's leading causes of blindness. In the UK, over 480,000 people are affected and millions worldwide.
In this short film, Renata Puertas, consultant ophthalmic surgeon at Moorfields Eye Hospital explains who should be getting checked for glaucoma:
Supporting vital research in glaucoma
To celebrate World Glaucoma Week, we are delighted to share short films of our researchers, clinicians and valued charity supporters to share their stories, research and experience of living with glaucoma.
Professor Sir Peng Tee Khaw, consultant ophthalmic surgeon and director of the NIHR Biomedical Research Centre at Moorfields Eye Hospital and UCL Institute of Ophthalmology
Professor Sir Peng Khaw conducts a wide variety of glaucoma research from developing safer surgical systems through to preclinical research with a view to developing new treatments for the prevention of scarring and regeneration of tissues after ocular surgery and disease. Surgery can be effective in reducing the pressure glaucoma cases inside the eye. However, some patients develop more scarring that others which can negatively impact the longer term success of their surgery. MEC is delighted to have supported a number of Peng’s projects over the years such as a PhD fellowship for a glaucoma clinician scientist working looking at a group of genes that control how badly the eye scars. The overall aim is to develop a drug that switches off the genes and prevents scarring taking place.
Peng tell’s us about the vision for glaucoma research and why philanthropy is vital:
Anthony’s research aims to discover the genetic markers that may predict why people develop glaucoma. Recent findings represent a major advance in the fight to tackle the degenerative condition which has virtually no symptoms in the early stages. This research opens up exciting new avenues to investigate, such as the potential for personalised glaucoma treatment, focusing the most effective treatments for patients at the highest risk to prevent blindness and enhance their outcomes.
MEC has provided over £100,000 for protected research time, enabling Anthony to advance his research programme in parallel with his clinical commitments.
Moorfields Eye Hospital's Glaucoma Clinic